Global Trac Solutions, Inc. CEO, David Flores, sits down once again with Founder & CEO of The Third Wave, Paul F. Austin. The two begin their conversation with accessibility & affordability, concepts that are commonly overlooked in psychedelic medicine. They then dive into what it would take to create an infrastructure that ensures a very important segment of our society is able to gain access to the powerful, and profound benefits available through the use of psychedelic medicine.
Similar Posts
Mushroom Chocolate: The New Wave in Mind Altering Edibles
From functional mushroom supplements to psilocybin laced bars, mushroom chocolate is a rapidly growing industry
New Research Shows “Bad Trips” Can Be Beneficial to Mental Health
New study has revealed that even adverse psychedelic experiences ( bad trips) can be beneficial to mental health.
Researchers to Hone In On Most Therapeutic Doses of LSD
New research is looking into the optimal dose of LSD to further enhance the therapeutic benefits of the psychedelic.
Can the Psychedelics Boom Go Bust? A Conversation with Cybin Chief Clinical Officer Dr. Alex Belser
“Something that people used to speak about only in whispers is now standard policy,” says the psychedelics researcher, with 20 years of experience, in a wide-ranging Q&A.
Study Reveals How Near-Death Experiences and Psychedelic Trips Change Our Concept on Mortality and Human Consciousness
A new study has sought to find the effect near-death experiences and psychedelic trips have on our thoughts of death, mortality, and more.
Guide to Ibogaine – The Ibogaine Experience, Benefits & Side Effects
This article aims to provide a comprehensive exploration of ibogaine, shedding light on its pharmacological mechanisms, potential therapeutic applications, benefits, risks, and the ethical considerations surrounding its use.